论文信息 - Phase I study of paclitaxel in combination with a multidrug resistance modulator, PSC 833 (Valspodar), in refractory malignancies. - 字舞流文

Phase I study of paclitaxel in combination with a multidrug resistance modulator, PSC 833 (Valspodar), in refractory malignancies.

P. Westervelt | P. Fracasso | E. Zuhowski | M. Egorin | D. Rosen | L. Cazenave | M. Litchman | C. L. Fears